Membrane transporters in drug development
Open accessThe DOI matches its Crossref record; 225 of the 225 references it cites were found in a registry or an index.
Abstract
Membrane transporters can be major determinants of the pharmacokinetic, safety and efficacy profiles of drugs. This presents several key questions for drug development, including which transporters are clinically important in drug absorption and disposition, and which in vitro methods are suitable for studying drug interactions with these transporters. In addition, what criteria should trigger follow-up clinical studies, and which clinical studies should be conducted if needed. In this article, we provide the recommendations of the International Transporter Consortium on these issues, and present decision trees that are intended to help guide clinical studies on the currently recognized most important drug transporter interactions. The recommendations are generally intended to support clinical development and filing of a new drug application. Overall, it is advised that the timing of transporter investigations should be driven by efficacy, safety and clinical trial enrolment questions (for example, exclusion and inclusion criteria), as well as a need for further understanding of the absorption, distribution, metabolism and excretion properties of the drug molecule, and information required for drug labelling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“To date, the human genome has been proven to have more than 400 membrane transporters, which are divided into two families: ATP binding cassette (ABC) and solute carrier (SLC) transporters [114].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [114]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
Schinkel, A. H., Smit, J. J. M., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Valk, M. A., Robanus-Maandag, E. C., te Riele, H. P. J., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90212-7 · Cited by 2,281
SLCO1B1 Variants and Statin-Induced Myopathy — A Genomewide Study
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801936 · Cited by 2,043
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
Aller, S. G., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R., Harrell, P. M., Trinh, Y. T., Zhang, Q., Urbatsch, I. L., et al. (2009) · Science · doi:10.1126/science.1168750 · Cited by 1,929
Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9004-4 · Cited by 1,401
Self-citationMammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00169-2 · Cited by 1,386
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.027 · Cited by 1,231
Cited by
Items 501–600 of 1,008
Brück, S., Strohmeier, J., Busch, D., Droździk, M., & Oswald, S. (2016) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2025 · Cited by 77
A Structural View on Medicinal Chemistry Strategies against Drug Resistance
Agnello, S., Brand, M., Chellat, M. F., Gazzola, S., & Riedl, R. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201802416 · Cited by 74
Ebner, T., Ishiguro, N., & Taub, M. E. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24489 · Cited by 73
Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics
Mooij, M. G., Nies, A. T., Knibbe, C. A. J., Schaeffeler, E., Tibboel, D., Schwab, M. G., & de Wildt, S. N. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0328-5 · Cited by 74
Takehara, I., Terashima, H., Nakayama, T., Yoshikado, T., Yoshida, M., Furihata, K., Watanabe, N., Maeda, K., Ando, O., Sugiyama, Y., et al. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2184-5 · Cited by 72
Self-citationSynergy of clavine alkaloid ‘chanoclavine’ with tetracycline against multi-drug-resistant E. coli
Dwivedi, G. R., Maurya, A., Yadav, D. K., Singh, V., Khan, F., Gupta, M. K., Singh, M., Darokar, M. P., & Srivastava, S. K. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1458654 · Cited by 72
Genetics of Clozapine-Associated Neutropenia: Recent Advances, Challenges and Future Perspective
Legge, S. E., & Walters, J. (2019) · Pharmacogenomics · doi:10.2217/pgs-2018-0188 · Cited by 78
An Overview of Cell-Based Assay Platforms for the Solute Carrier Family of Transporters
Dvorak, V., Wiedmer, T., Ingles-Prieto, A., Altermatt, P., Batoulis, H., Bärenz, F., Bender, E., Digles, D., Dürrenberger, F., Heitman, L. H., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.722889 · Cited by 67
Mitochondrial DNA Release Contributes to Intestinal Ischemia/Reperfusion Injury
Liao, S., Luo, J., Kadier, T., Ding, K., Chen, R., & Meng, Q. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.854994 · Cited by 77
Enzyme-based digital bioassay technology – key strategies and future perspectives
Noji, H., Minagawa, Y., & Ueno, H. (2022) · Lab on a Chip · doi:10.1039/d2lc00223j · Cited by 72
Targeted prodrugs in oral drug delivery: the modern molecular biopharmaceutical approach
Dahan, A., Khamis, M. I., Agbaria, R., & Karaman, R. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.697055 · Cited by 71
Yin, O. Q. P., Kimura, T., & Miller, R. (2014) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-014-1736-4 · Cited by 71
Grube, M., Ameling, S., Noutsias, M., Köck, K., Triebel, I., Bonitz, K., Meissner, K., Jedlitschky, G., Herda, L. R., Reinthaler, M., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.02.020 · Cited by 74
Li, M., de Graaf, I. A. M., & Groothuis, G. M. M. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2016.1125882 · Cited by 78
Moscovitz, J. E., Kalgutkar, A. S. S., Nulick, K., Johnson, N., Lin, Z., Goosen, T. C., & Weng, Y. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.247296 · Cited by 71
Feteisi, H. A., Al‐Majdoub, Z. M., Achour, B., Couto, N. A. S., Rostami‐Hodjegan, A., & Barber, J. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14446 · Cited by 74
Toyoda, Y., Mančíková, A., Krylov, V., Morimoto, K., Pavelcová, K., Bohatá, J., Pavelká, K., Pavlíková, M., Suzuki, H., Matsuo, H., et al. (2019) · Cells · doi:10.3390/cells8040363 · Cited by 73
Noncoding microRNAs: small RNAs play a big role in regulation of ADME?
Yu, A., & Pan, Y. (2012) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2012.02.011 · Cited by 72
Selective Inhibition of Human Solute Carrier Transporters by Multikinase Inhibitors
Johnston, R. A., Rawling, T., Chan, T., Zhou, F., & Murray, M. T. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.059097 · Cited by 73
Jansen, R. S., Mahakena, S., de Haas, M., Borst, P., & van de Wetering, K. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.692103 · Cited by 77
Keiser, M., Kaltheuner, L., Wildberg, C., Müller, J., Grube, M., Partecke, L. I., Heidecke, C.-D., & Oswald, S. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.04.001 · Cited by 75
Liu, H., Dong, K., Zhang, W., Summerfield, S. G., & Terstappen, G. C. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.03.002 · Cited by 74
Jones, N. S., Yoshida, K. J., Salphati, L., Kenny, J. R., Durk, M. R., & Chinn, L. W. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1599 · Cited by 74
Approaches to minimize the effects of P‐glycoprotein in drug transport: A review
Husain, A., Makadia, V., Valicherla, G. R., Riyazuddin, M., & Gayen, J. R. (2022) · Drug Development Research · doi:10.1002/ddr.21918 · Cited by 73
A structure and evolutionary-based classification of solute carriers
Ferrada, E., & Superti‐Furga, G. (2022) · iScience · doi:10.1016/j.isci.2022.105096 · Cited by 72
Chapy, H., Saubaméa, B., Tournier, N., Bourasset, F., Béhar‐Cohen, F., Declèves, X., Scherrmann, J., & Cisternino, S. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13376 · Cited by 69
Varma, M. V. S., Lin, J., Bi, Y., Kimoto, E., & Rodrigues, A. D. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.064303 · Cited by 70
Complete Knockout of Endogenous Mdr1 (Abcb1) in MDCK Cells by CRISPR-Cas9
Simoff, I., Karlgren, M., Backlund, M., Lindström, A.-C., Gaugaz, F. Z., Matsson, P., & Artursson, P. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/s0022-3549(15)00171-9 · Cited by 69
Negoro, R., Takayama, K., Kawai, K., Harada, K., Sakurai, F., Hirata, K., & Mizuguchi, H. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.10.019 · Cited by 75
Scalise, M., Pochini, L., Giangregorio, N., Tonazzi, A., & Indiveri, C. (2013) · Pharmaceutics · doi:10.3390/pharmaceutics5030472 · Cited by 68
Barton, H. A., Lai, Y., Goosen, T. C., Jones, H. M., El-Kattan, A. F., Gosset, J. R., Lin, J., & Varma, M. V. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.759210 · Cited by 68
Clinically relevant drug–drug interactions between antiretrovirals and antifungals
Vadlapatla, R. K., Patel, M., Paturi, D. K., Pal, D., & Mitra, A. K. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.883379 · Cited by 67
Ma, B., & Ma, Y. (2016) · Drug Metabolism Reviews · doi:10.3109/03602532.2015.1124888 · Cited by 70
Kumagai, Y., & Abiko, Y. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00326 · Cited by 75
Renal organic anion transporters in drug–drug interactions and diseases
Huo, X., & Liu, K. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.11.001 · Cited by 68
Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections
Tu, T., & Urban, S. (2018) · Current Opinion in Virology · doi:10.1016/j.coviro.2018.04.004 · Cited by 68
Zhang, F., Tagen, M., Throm, S., Mallari, J., Miller, L., Guy, R. K., Dyer, M. A., Williams, R. T., Roussel, M. F., Nemeth, K., et al. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035915 · Cited by 67
Bruderer, S., Äänismaa, P., Homery, M., Häusler, S., Landskroner, K., Sidharta, P. N., Treiber, A., & Dingemanse, J. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9316-3 · Cited by 67
Gammelgaard, B., Rasmussen, L. H., Gabel‐Jensen, C., & Steffansen, B. (2011) · Biological Trace Element Research · doi:10.1007/s12011-011-9174-y · Cited by 67
Regulatory Pathways for ATP-binding Cassette Transport Proteins in Kidney Proximal Tubules
Masereeuw, R., & Rüssel, F. G. M. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9404-z · Cited by 73
Clinical implications of drug–drug interactions with P2Y12 receptor inhibitors
Siller-Matula, J. M., Trenk, D., Krähenbühl, S., Michelson, A. D., & Delle‐Karth, G. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12445 · Cited by 67
Lee, N., Hébert, M. F., Prasad, B., Easterling, T. R., Kelly, E. J., Unadkat, J. D., & Wang, J. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.054072 · Cited by 67
Chapy, H., Smirnova, M., André, P., Schlatter, J., Chiadmi, F., Couraud, P., Scherrmann, J., Declèves, X., & Cisternino, S. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu001 · Cited by 67
In silico pharmacology: Drug membrane partitioning and crossing
Meo, F. D., Fabre, G., Berka, K., Ossman, T., Chantemargue, B., Paloncýová, M., Marquet, P., Otyepka, M., & Trouillas, P. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.06.030 · Cited by 71
Roles of organic anion transporters (OATs) in renal proximal tubules and their localization
Otani, N., Ouchi, M., Hayashi, K., Jutabha, P., & Anzai, N. (2016) · Anatomical Science International · doi:10.1007/s12565-016-0369-3 · Cited by 67
The ABCG2/BCRP transporter and its variants – from structure to pathology
Sarkadi, B., Homolya, L., & Hegedűs, T. (2020) · FEBS Letters · doi:10.1002/1873-3468.13947 · Cited by 68
Shirasaka, Y., Shichiri, M., Mori, T., Nakanishi, T., & Tamai, I. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23357 · Cited by 67
Commentary: Nonspecific Protein Binding versus Membrane Partitioning: It Is Not Just Semantics
Nagar, S., & Korzekwa, K. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.046599 · Cited by 70
Polysorbate-Based Drug Formulations for Brain-Targeted Drug Delivery and Anticancer Therapy
Ravichandran, V., Lee, M., Cao, T. G. N., & Shim, M. S. (2021) · Applied Sciences · doi:10.3390/app11199336 · Cited by 71
Chu, X., Prasad, B., Neuhoff, S., Yoshida, K. J., Leeder, J. S., Mukherjee, D., Taskar, K. S., Varma, M. V. S., Zhang, X., Yang, X., et al. (2022) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2643 · Cited by 68
Self-citationJiang, R., Dong, J., Li, X., Du, F., Jia, W., Xu, F., Wang, F., Yang, J., Niu, W., & Li, C. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12971 · Cited by 70
Ishikawa, T., Aw, W., & Kaneko, K. (2013) · Pharmaceuticals · doi:10.3390/ph6111347 · Cited by 66
Self-citationZamek‐Gliszczynski, M. J., Chu, X., Polli, J. W., Paine, M. F., & Galetin, A. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.055558 · Cited by 70
Self-citationBillington, S. F., Shoner, S. C., Lee, S. D., Clark‐Snustad, K., Pennington, M., Lewis, D., Muzi, M., Rene, S., Lee, J. Y. H., Nguyen, T. B., et al. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1506 · Cited by 66
Self-citationComparative Hepatic and Intestinal Efflux Transport of Statins
Deng, F. Y., Tuomi, S.-K., Neuvonen, M., Hirvensalo, P., Kulju, S., Wenzel, C., Oswald, S., Filppula, A. M., & Niemi, M. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000430 · Cited by 68
Self-citationChioukh, R., Noël‐Hudson, M., Ribes, S., Fournier, N., Becquemont, L., & Verstuyft, C. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.058529 · Cited by 65
Targeting uptake transporters for cancer imaging and treatment
Zhang, Y., & Wang, J. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.12.005 · Cited by 65
Loryan, I., Sinha, V., Mackie, C. E., Peer, A. V., Drinkenburg, W. H. I. M., Vermeulen, A., Heald, D., Hammarlund‐Udenaes, M., & Wassvik, C. M. (2014) · Molecular Pharmaceutics · doi:10.1021/mp5005965 · Cited by 70
Wang, Z., Chen, J., Wang, J., Ahn, S., Li, C.-M., Lü, Y., Loveless, V., Dalton, J. T., Miller, D. D., & Li, W. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0726-4 · Cited by 66
Brake, L. H. M. T., de Knegt, G. J., de Steenwinkel, J. E. M., van Dam, T. J. P., Burger, D. M., Rüssel, F. G. M., van Crevel, R., Koenderink, J. B., & Aarnoutse, R. E. (2017) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-052438 · Cited by 72
Curreli, F., Kwon, Y. D., Belov, D. S., Ramesh, R. R., Kurkin, A. V., Altieri, A., Kwong, P. D., & Debnath, A. K. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00179 · Cited by 67
Lee-Montiel, F. T., Laemmle, A., Charwat, V., Dumont, L., Lee, C. S., Huebsch, N., Okochi, H., Hancock, M. J., Siemons, B., Boggess, S. C., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.667010 · Cited by 54
Self-citationDai, T., Jiang, W., Guo, Z., Wang, Z., Huang, M., Zhong, G., Liang, C., Pei, X., & Dai, R. (2019) · Biomedical Chromatography · doi:10.1002/bmc.4573 · Cited by 64
Kramer, W. (2011) · Biological Chemistry · doi:10.1515/bc.2011.017 · Cited by 64
Bednarczyk, D. (2010) · Analytical Biochemistry · doi:10.1016/j.ab.2010.06.012 · Cited by 64
Gene Expression Variability in Human Hepatic Drug Metabolizing Enzymes and Transporters
Yang, L., Price, E. T., Chang, C., Li, Y., Huang, Y. S., Guo, L.-W., Guo, Y., Kaput, J., Shi, L. M., & Ning, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060368 · Cited by 66
Lima, Á., Bernardes, M., Azevedo, R., Monteiro, J., de Sousa, H. M. L., Medeiros, R., & Seabra, V. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu162 · Cited by 64
Erdő, F., Hashimoto, N., Karvaly, G., Nakamichi, N., & Kato, Y. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.035 · Cited by 64
Banerjee, J., Shi, Y., & Azevedo, H. S. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.05.020 · Cited by 74
In vitro screening of nanomedicines through the blood brain barrier: A critical review
Aparicio-Blanco, J., Martín‐Sabroso, C., & Torres‐Suárez, A. I. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.051 · Cited by 68
Fallon, J. K., Smith, P. C., Xia, C. Q., & Kim, M.-S. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1966-5 · Cited by 64
Expression, activity and pharmacokinetic impact of ocular transporters
Vellonen, K., Hellinen, L., Mannermaa, E., Ruponen, M., Urtti, A. O., & Kidron, H. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.12.009 · Cited by 69
Bellet, M., Ahmad, F., Villanueva-Vázquez, R., Valdivia, C., Palomino-Doza, J., Ruiz, A. I., González, X., Adrover, E., Azaro, A., Valls-Margarit, M., et al. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919833867 · Cited by 68
O’Hagan, S., & Kell, D. B. (2015) · PeerJ · doi:10.7717/peerj.1405 · Cited by 69
Chien, H.-C., Zur, A. A., Maurer, T. S., Yee, S. W., Tolsma, J., Jasper, P., Scott, D. O., & Giacomini, K. M. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.066647 · Cited by 63
“For many drugs to reach their intracellular target, passage through the lipoprotein bilayer of the cell membrane is facilitated by membrane transporters (Giacomini et al., 2010).”
BackgroundSelf-citationPharmacokinetic Drug Interactions of Afatinib with Rifampicin and Ritonavir
Wind, S., Giessmann, T., Jungnik, A., Brand, T., Marzin, K., Bertulis, J., Hocke, J., Gansser, D., & Stopfer, P. (2014) · Clinical Drug Investigation · doi:10.1007/s40261-013-0161-2 · Cited by 63
Nanoplatform-based natural products co-delivery system to surmount cancer multidrug-resistant
Liang, Y., Liu, Z.-Y., Wang, P., Li, Y., Wang, R., & Xie, S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.06.034 · Cited by 65
Lakhera, S., Devlal, K., Ghosh, A., & Rana, M. M. (2021) · Results in Chemistry · doi:10.1016/j.rechem.2021.100199 · Cited by 63
Teng, M., & Gray, N. S. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.06.020 · Cited by 66
Multiple mechanisms of ligand interaction with the human organic cation transporter, OCT2
Harper, J. N., & Wright, S. H. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00486.2012 · Cited by 63
Self-citationYeo, K. R., Jamei, M., & Rostami‐Hodjegan, A. (2013) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.13.4 · Cited by 63
Varma, M. V. S., Bi, Y., Kimoto, E., & Lin, J. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.215970 · Cited by 65
Lai, Y., Varma, M. V. S., Feng, B., Stephens, J. C., Kimoto, E., El‐Kattan, A. F., Ichikawa, K., Kikkawa, H., Ono, C., Suzuki, A., et al. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.678048 · Cited by 66
Functional Maturation of Drug Transporters in the Developing, Neonatal, and Postnatal Kidney
Sweeney, D. E., Vallon, V., Rieg, T., Wu, W., Gallegos, T. F., & Nigám, S. K. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.070680 · Cited by 63
Fan, J., Chen, S., C.Y. Chow, E., & Sandy Pang, K. (2010) · Current Drug Metabolism · doi:10.2174/138920010794328931 · Cited by 62
Zhang, D., Frost, C. E., He, K., Rodrigues, A. D., Wang, X., Wang, L., Goosen, T. C., & Humphreys, W. G. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.050575 · Cited by 64
Izumi, S., Nozaki, Y., Komori, T., Takenaka, O., Maeda, K., Kusuhara, H., & Sugiyama, Y. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00664 · Cited by 63
Self-citationChen, E. C., Khuri, N., Liang, X., Stecuła, A., Chien, H., Yee, S. W., Huang, Y. L., Šali, A., & Giacomini, K. M. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01317 · Cited by 63
Self-citationChen, Y., Cheng, Y., Zhao, P., Zhang, S., Li, M., He, C., Zhang, X., Yang, T., Yan, R., Ye, P., et al. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.03.024 · Cited by 63
Pharmacological characterization of the 3D MucilAir™ nasal model
Mercier, C., Jacqueroux, E., Hé, Z., Hodin, S., Constant, S., Perek, N., Boudard, D., & Delavenne, X. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.04.002 · Cited by 63
The ABCG2 multidrug transporter is a pump gated by a valve and an extracellular lid
Khunweeraphong, N., Szöllősi, D., Stockner, T., & Kuchler, K. (2019) · Nature Communications · doi:10.1038/s41467-019-13302-2 · Cited by 64
Bi, Y., Kimoto, E., Sevidal, S., Jones, H. M., Barton, H. A., Kempshall, S., Whalen, K. M., Zhang, H., Ji, C., Fenner, K. S., et al. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.043489 · Cited by 65
Fortuna, A. C., Alves, G., Falcão, A. C., & Soares-da-Silva, P. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03409.x · Cited by 70
Long‐Term Stability of Primary Rat Hepatocytes in Micropatterned Cocultures
Ukairo, O., Kanchagar, C., Moore, A., Shi, J., Gaffney, J., Aoyama, S., Rose, K., Krzyzewski, S., McGeehan, J., Andersen, M. E., et al. (2013) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21469 · Cited by 61
Iwao, T., Toyota, M., Miyagawa, Y., Okita, H., Kiyokawa, N., Akutsu, H., Umezawa, A., Nagata, K., & Matsunaga, T. (2013) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-13-rg-005 · Cited by 63
Dahlin, A., Geier, E., Stocker, S. L., Cropp, C. D., Grigorenko, E., Bloomer, M., Siegenthaler, J., Xu, L., Basile, A. S., Tang-Liu, D. D.-S., et al. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300429e · Cited by 61
Self-citationThe pharmacology of novel oral anticoagulants
DeWald, T. A., & Becker, R. C. (2013) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-013-0967-z · Cited by 62
Steroid hormones specifically modify the activity of organic anion transporting polypeptides
Koenen, A., Köck, K., Keiser, M., Siegmund, W., Kroemer, H. K., & Grube, M. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.08.017 · Cited by 62
Balogh, L. M. (2013) · Journal of Proteomics & Bioinformatics · doi:10.4172/jpb.1000285 · Cited by 67
Natural Polyphenols in Cancer Chemoresistance
Hussain, S. A., Sulaiman, A. A., Balch, C., Chauhan, H., Alhadidi, Q., & Tiwari, A. K. (2016) · Nutrition and Cancer · doi:10.1080/01635581.2016.1192201 · Cited by 67
Metadata
- Authors
- The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., Hillgren, K. M., Hoffmaster, K. A., Ishikawa, T., Keppler, D., Kim, R. B., Lee, C. A., Niemi, M., Polli, J. W., Sugiyama, Y., Swaan, P. W., Ware, J. A., Wright, S. H., Wah Yee, S., Zamek-Gliszczynski, M. J., & Zhang, L.
- Affiliations
- University of California, San Francisco (US)
- United States Food and Drug Administration (US)
- Boehringer Ingelheim (United States) (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Abbott (United States) (US)
- Eli Lilly (United States) (US)
- Novartis (United States) (US)
- RIKEN (JP)
- German Cancer Research Center (DE)
- Western University (CA)
- GlaxoSmithKline (United Kingdom) (GB)
- Genentech (US)
- University of Maryland, Baltimore (US)
- University of Arizona (US)
- ORCID
- Venue
- Nature Reviews Drug Discovery
- Published
- 2010-03
- Volume
- 9
- Issue
- 3
- Pages
- 215-236
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC3326076
- OpenAlex
- W2079197876
- Cited by
- 3,340
- References
- 225
- Citations by year
- 2026: 105 · 2025: 118 · 2024: 153 · 2023: 175 · 2022: 180 · 2021: 237 · 2020: 187 · 2019: 219 · 2018: 234 · 2017: 216 · 2016: 242 · 2015: 233 · 2014: 248 · 2013: 316 · 2012: 254
- FWCI
- 27.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Scholarship@Western (Western University) (submittedVersion)
- Funders
- National Institutes of Health (GM61390)
- U.S. Food and Drug Administration
- National Institute of General Medical Sciences (GM61390, R01GM041935, U19GM061390, U01GM061390)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK080801, R01DK061425)
- National Institute of Environmental Health Sciences (P30ES006694)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Keywords
- membrane transporters, drug transporters, drug-drug interactions, pharmacokinetics, drug absorption, drug disposition, drug development, drug safety and efficacy, drug labeling
- MeSH terms
- Animals, Computer Simulation, Decision Trees, Drug Interactions, Drug Evaluation, Preclinical, Humans, Drug Approval, Mice, Knockout, Membrane Transport Proteins, Mice, Prescription Drugs, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.